AAAAAA
Results:
1-15
|
Results: 15
Authors:
Deichmann, M
Benner, A
Kuner, N
Wacker, J
Waldmann, V
Naher, H
Citation: M. Deichmann et al., Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100 beta or melanoma inhibitory activity (MIA)?, MELANOMA RE, 11(3), 2001, pp. 291-296
Authors:
Eickholz, P
Kugel, B
Pohl, S
Naher, H
Staehle, HJ
Citation: P. Eickholz et al., Combined mechanical and antibiotic periodontal therapy in a case of Papillon-Lefevre syndrome, J PERIODONT, 72(4), 2001, pp. 542-549
Authors:
Durani, BK
Bock, M
Naher, H
Citation: Bk. Durani et al., Extracorporeal photopheresis - successful treatment option for scleromyxedema?, HAUTARZT, 52, 2001, pp. 938-941
Authors:
Jackel, A
Bock, M
Deichmann, M
Waldmann, V
Naher, H
Citation: A. Jackel et al., Therapy of metastatic malignant uveal melanoma, HAUTARZT, 52(2), 2001, pp. 98-103
Authors:
Wagner, V
Rudi, J
Naher, H
Stremmel, W
Citation: V. Wagner et al., Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas, MED ONCOL, 17(1), 2000, pp. 35-38
Authors:
Waldmann, V
Wacker, J
Deichmann, M
Naher, H
Citation: V. Waldmann et al., No correlation of tyrosinase mRNA in bone marrow with prognosis of metastatic melanoma, DERMATOLOGY, 201(1), 2000, pp. 6-9
Authors:
Deichmann, M
Benner, A
Waldmann, V
Bock, M
Jackel, A
Naher, H
Citation: M. Deichmann et al., Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma, J EXP CL C, 19(3), 2000, pp. 301-307
Authors:
Waldmann, V
Goldschmidt, H
Jackel, A
Deichmann, M
Hegenbart, U
Hartschuh, W
Ho, A
Naher, H
Citation: V. Waldmann et al., Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation, BR J DERM, 143(4), 2000, pp. 837-839
Authors:
Deichmann, M
Benner, A
Bock, M
Jackel, A
Uhl, K
Waldmann, V
Naher, H
Citation: M. Deichmann et al., S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma, J CL ONCOL, 17(6), 1999, pp. 1891-1896
Authors:
Waldmann, V
Bock, M
Jackel, A
Deichmann, M
Dockendorff, K
Naher, H
Citation: V. Waldmann et al., Molecular biology of malignant melanoma, HAUTARZT, 50(6), 1999, pp. 398-405
Authors:
Jackel, A
Deichmann, M
Waldmann, V
Bock, M
Naher, H
Citation: A. Jackel et al., S-100 beta protein in serum, a tumor marker in malignant melanoma - current state of knowledge and clinical experiences, HAUTARZT, 50(4), 1999, pp. 250-256
Authors:
Waldmann, V
Deichmann, M
Bock, M
Jackel, A
Naher, H
Citation: V. Waldmann et al., The detection of tyrosinase-specific mRNA in bone marrow is not more sensitive than in blood for the demonstration of micrometastatic melanoma, BR J DERM, 140(6), 1999, pp. 1060-1064
Authors:
Jackel, A
Deichmann, M
Waldmann, V
Bock, M
Naher, H
Citation: A. Jackel et al., Regression of metastatic angiosarcoma of the skin after systemic treatmentwith liposome-encapsulated doxorubicin and interferon-alpha, BR J DERM, 140(6), 1999, pp. 1187-1188
Authors:
Deichmann, M
Thome, M
Bock, M
Jackel, A
Waldmann, V
Naher, H
Citation: M. Deichmann et al., The human herpesvirus-type 8 is not involved in malignant melanoma, BR J CANC, 80(1-2), 1999, pp. 67-69
Authors:
Deichmann, M
Thome, M
Jackel, A
Utermann, S
Bock, M
Waldmann, V
Naher, H
Citation: M. Deichmann et al., Non-human immunodeficiency virus Kaposi's sarcoma can be effectively treated with low-dose interferon-alpha despite the persistence of herpesvirus-8, BR J DERM, 139(6), 1998, pp. 1052-1054
Risultati:
1-15
|